GRACEcast-084_Lung-Cancer_ALK Inhibition: Science and Early Clinical Experience by Dr. Ben Solomon
6 Bekeken
• 07/30/23
0
0
insluiten
administrator
abonnees
http://cancergrace.org/
Dr. Ben Solomon of Peter MacCallum Cancer Centre in Melbourne Australia reviews ALK Inhibition from mechanism of action to activity and side effect profile of crizotinib, newly approved for patients with ALK-positive advanced non-small cell lung cancer.
Laat meer zien
Facebook Reacties
SORT BY-
Top Reacties
-
Laatste Reacties